MEF2C antibody (pSer222)
Quick Overview for MEF2C antibody (pSer222) (ABIN6254109)
Target
See all MEF2C AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- pSer222
-
Cross-Reactivity
- Human
-
Predicted Reactivity
- bovine, chicken, guinea pig, mouse, non-human primate, rat, sheep
-
Purification
- Antigen Affinity Purified from Pooled Serum
-
Immunogen
- Synthetic phospho-peptide corresponding to amino acid residues surrounding Ser222 conjugated to KLH
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Buffer
- 100 μL in 10 mM HEPES ( pH 7.5), 150 mM NaCl, 100 μg per ml BSA and 50 % glycerol.
-
Storage
- -20 °C
-
-
-
MEF2C Phosphorylation Is Required for Chemotherapy Resistance in Acute Myeloid Leukemia. ..." in: Cancer discovery, Vol. 8, Issue 4, pp. 478-497, (2019) (PubMed).
: "
-
MEF2C Phosphorylation Is Required for Chemotherapy Resistance in Acute Myeloid Leukemia. ..." in: Cancer discovery, Vol. 8, Issue 4, pp. 478-497, (2019) (PubMed).
-
- MEF2C (Myocyte Enhancer Factor 2C (MEF2C))
-
Alternative Name
- MEF2C
-
Molecular Weight
- '51 kDa
-
Gene ID
- 4208
-
UniProt
- Q06413
-
Pathways
- Neurotrophin Signaling Pathway, Activation of Innate immune Response, Cellular Response to Molecule of Bacterial Origin, Carbohydrate Homeostasis, Chromatin Binding, Regulation of Muscle Cell Differentiation, Skeletal Muscle Fiber Development, Toll-Like Receptors Cascades, BCR Signaling
Target
-